996 Mrv0541 02231215102D 12 12 0 0 0 0 999 V2000 4.7934 1.5395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.7934 0.1106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.9058 0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.1433 0.1106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4289 -0.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8578 -0.3020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4289 -1.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8578 -1.1270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.1433 -1.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5558 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.7308 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3808 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 12 1 0 0 0 0 2 12 2 0 0 0 0 3 11 1 0 0 0 0 4 5 1 0 0 0 0 4 6 1 0 0 0 0 4 10 1 0 0 0 0 4 11 1 0 0 0 0 5 7 1 0 0 0 0 6 8 1 0 0 0 0 7 9 1 0 0 0 0 8 9 1 0 0 0 0 10 12 1 0 0 0 0 M END > DB00996 > approved; investigational > Gabapentin > Gabapentin GR; Gabapentine [INN-French]; Gabapentino [INN-Spanish]; Gabapentino [Spanish]; Gabapentinum [INN-Latin]; Gabapetin > Aclonium; Neurontin; Novo-Gabapentin > C9H17NO2 > 171.2368 > 171.125928793 > 2-[1-(aminomethyl)cyclohexyl]acetic acid > InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12) > InChIKey=UGJMXCAKCUNAIE-UHFFFAOYSA-N > NCC1(CC(O)=O)CCCCC1 > 3 > 2 > -1.9 > -1.3 > -1.6 > 18.92 > 63.32 > 46.33 > 3 > 4.34e+00 g/l $$$$